Lung Cancer Trial, By Invitation NCT06752395 Sponsor: Pusan National University Hospital Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, By Invitation

NCT06752395
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are 18 years of age or older.
  • People who have provided written consent to participate.
  • People who have a nodule smaller than 30mm shown on a CT scan.
  • People who do not have any medical reason that would prevent them from safely having a bronchoscopy (a procedure where a thin tube is passed into the airways to examine the lungs).

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose lung lesion is located in a central airway and can already be seen directly through a standard bronchoscopy, or who have signs that cancer may have spread to lymph nodes in the chest, meaning a special ultrasound probe (RP-EBUS) is not needed.
  • People who are unable to stop taking medications that raise the risk of bleeding, such as blood thinners or antiplatelet drugs.
  • People who have a bleeding disorder, for example a platelet count below 100,000/mm³ (a measure of clotting cells in the blood) (confirm with trial site).
  • People who have serious health conditions, such as severe heart or lung disease, that would make having a bronchoscopy unsafe.
  • People who have a known allergy or sensitivity to medications commonly used during bronchoscopy procedures, including lidocaine, midazolam, fentanyl, or flumazenil.
  • People who are pregnant or currently breastfeeding.
  • People who have already been diagnosed with lung cancer and are having a repeat biopsy for genetic testing or other purposes.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Pusan National University Hospital
Registry
ClinicalTrials.gov
Start date
1 November 2024
Est. completion
1 November 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

The overall cumulative diagnostic yield

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov